Implantation in Posterior Maxilla in Cases With Insufficient Bone (NCT06468592) | Clinical Trial Compass
CompletedNot Applicable
Implantation in Posterior Maxilla in Cases With Insufficient Bone
Syria31 participantsStarted 2022-03-02
Plain-language summary
Dental implant procedures are performed on two groups of individuals who share the common characteristic of insufficient bone for traditional implantation.
The first group lacks a palatal process, while the second group has a palatal process. Then, compare the initial primary stability of implants in the maxillary bone-type (D4) that were inserted tilted in the palatal process of the maxilla, palatally from the maxillary sinus, with implants inserted axially into the maxillary sinus by using a manual torque wrench.
Who can participate
Age range
32 Years – 73 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria for both groups:
* Patients must have inadequate bone density in the posterior region of the upper jaw.
* Patients should maintain good oral hygiene.
* The surgical site must be free from infection.
* There should be no contraindications for oral surgery.
For the first group:
\- Patients in the first group must have a palatal process of the maxillary bone determined by radiographic examination.
Exclusion criteria:
* Patients with adequate bone volume to receive an implant.
* Patients with systemic diseases that impair metabolism or healing at the surgical site.
* Patients with contraindications for surgery, including cardiovascular disorders, blood clotting disorders, anticoagulant use, or uncontrolled diabetes.
* Patients receiving medications that affect bone metabolism, such as corticosteroids, oral contraceptives, hormonal treatments, or those undergoing chemical or radiological therapies.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The initial implant stability
Timeframe: one time assessment at five minutes following the completion of inserting implants.